Loading financial statements…
Import this data to Google Sheets with:
=jivedata("ESGH","financials")Full statements spill as a table. For one cell: =jivedata("ESGH","Revenue") or =jivedata("ESGH","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
ESGH • CIK 0001883835
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenue from Contract with Customer, Including Assessed Tax | — | $12,682.33 | $6,122.633 | $6,122.633 |
| Cost of Revenue | — | $9,134.997 | $5,605.113 | $2,691.786 |
| Gross Profit | — | $3,547.333 | $517.52 | $-645.415 |
| Operating Expenses | $37.855 | $1,859.681 | $2,767.044 | $2,278.087 |
| Operating Income (Loss) | $-37.855 | $1,687.652 | $-2,249.524 | $-2,923.502 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $-37.584 | $1,247.853 | $-2,503.173 | $-3,098.559 |
| Net Income (Loss) Attributable to Noncontrolling Interest | — | $303.22 | $-555.855 | $-459.186 |
| Net Income (Loss) Attributable to Parent | $-37.584 | $944.633 | $-1,947.318 | $-3,093.659 |
| Weighted Average Number of Shares Outstanding, Basic | 15,466,668 | 25,899,468 | 25,899,468 | 23,848,509 |
| Selling, General and Administrative Expense | — | $1,150.927 | $2,404.532 | $2,121.131 |
| Research and Development Expense | — | $708.754 | $362.512 | $362.512 |
| Interest Income (Expense), Nonoperating, Net | — | $-653.114 | $-524.722 | $-517.331 |
| Other Nonoperating Income (Expense) | — | $213.315 | $271.073 | $168.146 |
| Nonoperating Income (Expense) | — | $-439.799 | $-253.649 | $-349.186 |
| Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | — | $-281.064 | $400.393 | $243.54 |
| Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Noncontrolling Interest | — | $96.102 | $-136.903 | $53.431 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | — | $663.569 | $-1,546.925 | $-2,803.913 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest | — | $207.118 | $-418.952 | $-793.534 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash | — | $110.343 | $42.978 | $161.1 |
| Restricted Cash, Current | — | $56.398 | $36.892 | $37.912 |
| Assets | $47.218 | $29,794.057 | $26,933.159 | $190.777 |
| Accounts and Other Receivables, Net, Current | — | $2,917.093 | $3,223.334 | $3,089.551 |
| Inventory, Net | — | $2,906.383 | $112.25 | $29.645 |
| Other Receivables, Net, Current | — | $245.232 | $432.458 | $438.781 |
| Prepaid Supplies | — | $736.094 | $837.152 | $849.392 |
| Value Added Tax Receivable, Current | — | — | $2,104.253 | $2,104.253 |
| Assets, Current | $46.449 | $6,971.543 | $6,789.317 | $190.745 |
| Property, Plant and Equipment, Net | $0.769 | $17,184.192 | $16,313.411 | $0.032 |
| Finite-Lived Intangible Assets, Net | — | $2,934.213 | $2,992.157 | $3,018.625 |
| Value Added Tax Receivable, Noncurrent | — | $2,704.109 | $838.274 | $880.901 |
| Assets, Noncurrent | — | $22,822.514 | $20,143.842 | $0.032 |
| Liabilities, Current | $1 | $13,806.885 | $13,097.741 | $564.916 |
| Deferred Income | — | $1,073.487 | $1,022.465 | $1,012.878 |
| Liabilities, Noncurrent | — | $2,169.177 | $1,983.3 | $1,944.391 |
| Liabilities | $1 | $15,976.062 | $15,081.041 | $564.916 |
| Short-term Bank Loans and Notes Payable | — | $5,988.024 | $6,146.809 | $6,236.675 |
| Convertible Notes Payable | — | — | $275 | $495 |
| Accounts Payable, Current | $1 | $4,604.011 | $1,534.421 | $64.324 |
| Other Accrued Liabilities, Current | — | $3,092.953 | $5,030.921 | $5,291.184 |
| Deferred Income, Current | — | $121.897 | $110.59 | $110.59 |
| Common Stock, Value, Issued | $15.467 | $25.9 | $25.9 | $15.592 |
| Additional Paid in Capital | $124.7 | $11,152.388 | $200 | $686.412 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | — | $-711.27 | $-310.877 | $-180.791 |
| Retained Earnings (Accumulated Deficit) | $-93.949 | $-168.6 | $-2,115.918 | $-1,076.143 |
| Stockholders' Equity Attributable to Parent | $46.218 | $10,298.418 | $8,751.493 | $-374.139 |
| Stockholders' Equity Attributable to Noncontrolling Interest | — | $3,519.577 | $3,100.625 | $2,943.268 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | — | $13,817.995 | $11,852.118 | $-374.139 |
| Common Stock, Shares Authorized | 65,000,000 | 65,000,000 | 65,000,000 | 65,000,000 |
| Common Stock, Shares, Issued | 15,466,668 | 25,899,468 | 25,899,468 | 15,591,376 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | $-2,503.173 | $-3,111.07 |
| Net Cash Provided by (Used in) Operating Activities | $-39.69 | $1,546.524 | $101.246 | $1,574.676 |
| Net Cash Provided by (Used in) Investing Activities | $-40 | $-685.056 | $-178.227 | $-178.227 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $-79.69 | $-175.601 | $-86.871 | $31.727 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $6.449 | $166.741 | $79.87 | $108.692 |
| IncomeTaxPaidForeignAfterRefundReceived | — | — | $-238.706 | $-238.706 |
| Depreciation, Depletion and Amortization | — | $1,765.929 | $1,837.181 | $914.586 |
| Increase (Decrease) in Other Accounts Payable | — | $828.191 | $828.191 | $828.191 |
| Increase (Decrease) in Notes Payable, Related Parties | — | $-30 | $-30 | $-30 |
| Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net | — | — | $-1,937.968 | $-1,635.007 |
| Increase (Decrease) in Deferred Income Taxes | — | $124.914 | $62.329 | $62.329 |
| Payments to Acquire Property, Plant, and Equipment | $1.289 | $685.056 | $178.227 | $178.227 |
| Proceeds from Loans | — | $7,271.714 | $1,121.025 | $1,121.025 |
| Repayments of Bank Debt | — | $8,010.03 | $97.394 | $97.394 |
| Payments for Loans | — | $293.064 | $134.854 | $134.854 |
| Net Cash Provided by (Used in) Financing Activities | — | $-1,031.38 | $888.777 | $-252.476 |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | $-5.688 | $-898.667 | $-1,282.007 |
| Increase (Decrease) in Accounts and Other Receivables | — | $2,965.613 | $306.241 | $891 |
| Increase (Decrease) in Other Receivables | — | $170.988 | $187.226 | $187.226 |
| Increase (Decrease) in Inventories | — | $1,322.075 | $-2,794.133 | $-1,928.618 |
| Increase (Decrease) in Notes Receivables | — | $-41.374 | $-41.374 | $-41.374 |
| Increase (Decrease) in Accounts Payable | $-2.366 | $3,423.166 | $-3,069.59 | $66.654 |